BlackRock Institutional Trust’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $7.41M | Buy |
2,344,623
+72,761
| +3% | +$230K | ﹤0.01% | 2572 |
|
|
2016
Q3 | $7.75M | Buy |
2,271,862
+68,023
| +3% | +$232K | ﹤0.01% | 2487 |
|
|
2016
Q2 | $5.03M | Buy |
2,203,839
+18,784
| +0.9% | +$42.9K | ﹤0.01% | 2674 |
|
|
2016
Q1 | $5.49M | Sell |
2,185,055
-190,599
| -8% | -$479K | ﹤0.01% | 2600 |
|
|
2015
Q4 | $7.86M | Buy |
2,375,654
+103,515
| +5% | +$343K | ﹤0.01% | 2480 |
|
|
2015
Q3 | $5.5M | Sell |
2,272,139
-87,510
| -4% | -$212K | ﹤0.01% | 2660 |
|
|
2015
Q2 | $6.91M | Sell |
2,359,649
-8,555
| -0.4% | -$25.1K | ﹤0.01% | 2604 |
|
|
2015
Q1 | $9.5M | Buy |
2,368,204
+63,274
| +3% | +$254K | ﹤0.01% | 2417 |
|
|
2014
Q4 | $6.94M | Buy |
2,304,930
+1,011
| +0% | +$3.04K | ﹤0.01% | 2564 |
|
|
2014
Q3 | $5.84M | Buy |
2,303,919
+120,133
| +6% | +$304K | ﹤0.01% | 2614 |
|
|
2014
Q2 | $5.38M | Buy |
2,183,786
+126,595
| +6% | +$312K | ﹤0.01% | 2750 |
|
|
2014
Q1 | $5.46M | Buy |
2,057,191
+267,451
| +15% | +$710K | ﹤0.01% | 2745 |
|
|
2013
Q4 | $5.2M | Buy |
1,789,740
+152,790
| +9% | +$444K | ﹤0.01% | 2762 |
|
|
2013
Q3 | $5.02M | Buy |
1,636,950
+37,765
| +2% | +$116K | ﹤0.01% | 2728 |
|
|
2013
Q2 | $5.11M | Buy |
+1,599,185
| New | +$5.11M | ﹤0.01% | 2686 |
|